0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Needle-free Drug Injectors Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-20D18907
Home | Market Reports | Business & Industrial| Energy & Utilities| Oil & Gas
Global Needle free Drug Injectors Market Research Report 2024
BUY CHAPTERS

Global Needle-free Drug Injectors Market Research Report 2024

Code: QYRE-Auto-20D18907
Report
December 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Needle-free Drug Injectors Market Size

The global market for Needle-free Drug Injectors was valued at US$ 222 million in the year 2023 and is projected to reach a revised size of US$ 315 million by 2030, growing at a CAGR of 5.0% during the forecast period.

Needle-free Drug Injectors Market

Needle-free Drug Injectors Market

Needle-free drug injectors are advanced drug delivery technologies that dispense with the use of traditional syringes and needles in favor of the rapid delivery of drugs to subcutaneous or muscular tissues by means of high-speed liquid streams or other means that penetrate directly into the skin. These systems typically employ the high-pressure injection principle, which utilizes a compressed gas or spring-loaded device to generate sufficient pressure to allow the liquid drug to penetrate the skin barrier and enter the body in the form of an extremely fine, high-speed stream. Needle-free drug injectors are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
North American market for Needle-free Drug Injectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Needle-free Drug Injectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Needle-free Drug Injectors include Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Needle-free Drug Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-free Drug Injectors.
The Needle-free Drug Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Needle-free Drug Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-free Drug Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Needle-free Drug Injectors Market Report

Report Metric Details
Report Name Needle-free Drug Injectors Market
Accounted market size in year US$ 222 million
Forecasted market size in 2030 US$ 315 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2030
by Type
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, PharmaJet, Portal Instruments, Crossject, Mika Medical, Ferring Pharmaceuticals, IntegriMedical, Helcomin, Nugen Medical, Lepu Medical, Beijing Quinovare, Qingdao Zhonghui Health Industrial Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Needle-free Drug Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Needle-free Drug Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Needle-free Drug Injectors Market growing?

Ans: The Needle-free Drug Injectors Market witnessing a CAGR of 5.0% during the forecast period 2025-2030.

What is the Needle-free Drug Injectors Market size in 2030?

Ans: The Needle-free Drug Injectors Market size in 2030 will be US$ 315 million.

Who are the main players in the Needle-free Drug Injectors Market report?

Ans: The main players in the Needle-free Drug Injectors Market are Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, PharmaJet, Portal Instruments, Crossject, Mika Medical, Ferring Pharmaceuticals, IntegriMedical, Helcomin, Nugen Medical, Lepu Medical, Beijing Quinovare, Qingdao Zhonghui Health Industrial Group

What are the Application segmentation covered in the Needle-free Drug Injectors Market report?

Ans: The Applications covered in the Needle-free Drug Injectors Market report are Vaccine Delivery, Insulin Delivery, Others

What are the Type segmentation covered in the Needle-free Drug Injectors Market report?

Ans: The Types covered in the Needle-free Drug Injectors Market report are Powder Injections, Liquid Injections, Depot or Projectile Injection

Recommended Reports

Needle-Free Injection

Drug Delivery Devices

Needle/Infusion Accessories

1 Needle-free Drug Injectors Market Overview
1.1 Product Definition
1.2 Needle-free Drug Injectors by Type
1.2.1 Global Needle-free Drug Injectors Market Value Comparison by Type (2024-2030)
1.2.2 Powder Injections
1.2.3 Liquid Injections
1.2.4 Depot or Projectile Injection
1.3 Needle-free Drug Injectors by Application
1.3.1 Global Needle-free Drug Injectors Market Value by Application (2024-2030)
1.3.2 Vaccine Delivery
1.3.3 Insulin Delivery
1.3.4 Others
1.4 Global Needle-free Drug Injectors Market Size Estimates and Forecasts
1.4.1 Global Needle-free Drug Injectors Revenue 2019-2030
1.4.2 Global Needle-free Drug Injectors Sales 2019-2030
1.4.3 Global Needle-free Drug Injectors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Needle-free Drug Injectors Market Competition by Manufacturers
2.1 Global Needle-free Drug Injectors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Needle-free Drug Injectors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Needle-free Drug Injectors Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Needle-free Drug Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Needle-free Drug Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Needle-free Drug Injectors, Product Type & Application
2.7 Global Key Manufacturers of Needle-free Drug Injectors, Date of Enter into This Industry
2.8 Global Needle-free Drug Injectors Market Competitive Situation and Trends
2.8.1 Global Needle-free Drug Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Needle-free Drug Injectors Players Market Share by Revenue
2.8.3 Global Needle-free Drug Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Needle-free Drug Injectors Market Scenario by Region
3.1 Global Needle-free Drug Injectors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Needle-free Drug Injectors Sales by Region: 2019-2030
3.2.1 Global Needle-free Drug Injectors Sales by Region: 2019-2024
3.2.2 Global Needle-free Drug Injectors Sales by Region: 2025-2030
3.3 Global Needle-free Drug Injectors Revenue by Region: 2019-2030
3.3.1 Global Needle-free Drug Injectors Revenue by Region: 2019-2024
3.3.2 Global Needle-free Drug Injectors Revenue by Region: 2025-2030
3.4 North America Needle-free Drug Injectors Market Facts & Figures by Country
3.4.1 North America Needle-free Drug Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Needle-free Drug Injectors Sales by Country (2019-2030)
3.4.3 North America Needle-free Drug Injectors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Needle-free Drug Injectors Market Facts & Figures by Country
3.5.1 Europe Needle-free Drug Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Needle-free Drug Injectors Sales by Country (2019-2030)
3.5.3 Europe Needle-free Drug Injectors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-free Drug Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific Needle-free Drug Injectors Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Needle-free Drug Injectors Sales by Region (2019-2030)
3.6.3 Asia Pacific Needle-free Drug Injectors Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Needle-free Drug Injectors Market Facts & Figures by Country
3.7.1 Latin America Needle-free Drug Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Needle-free Drug Injectors Sales by Country (2019-2030)
3.7.3 Latin America Needle-free Drug Injectors Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Needle-free Drug Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Needle-free Drug Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Needle-free Drug Injectors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Needle-free Drug Injectors Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Needle-free Drug Injectors Sales by Type (2019-2030)
4.1.1 Global Needle-free Drug Injectors Sales by Type (2019-2024)
4.1.2 Global Needle-free Drug Injectors Sales by Type (2025-2030)
4.1.3 Global Needle-free Drug Injectors Sales Market Share by Type (2019-2030)
4.2 Global Needle-free Drug Injectors Revenue by Type (2019-2030)
4.2.1 Global Needle-free Drug Injectors Revenue by Type (2019-2024)
4.2.2 Global Needle-free Drug Injectors Revenue by Type (2025-2030)
4.2.3 Global Needle-free Drug Injectors Revenue Market Share by Type (2019-2030)
4.3 Global Needle-free Drug Injectors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Needle-free Drug Injectors Sales by Application (2019-2030)
5.1.1 Global Needle-free Drug Injectors Sales by Application (2019-2024)
5.1.2 Global Needle-free Drug Injectors Sales by Application (2025-2030)
5.1.3 Global Needle-free Drug Injectors Sales Market Share by Application (2019-2030)
5.2 Global Needle-free Drug Injectors Revenue by Application (2019-2030)
5.2.1 Global Needle-free Drug Injectors Revenue by Application (2019-2024)
5.2.2 Global Needle-free Drug Injectors Revenue by Application (2025-2030)
5.2.3 Global Needle-free Drug Injectors Revenue Market Share by Application (2019-2030)
5.3 Global Needle-free Drug Injectors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Halozyme (Antares Pharma)
6.1.1 Halozyme (Antares Pharma) Company Information
6.1.2 Halozyme (Antares Pharma) Description and Business Overview
6.1.3 Halozyme (Antares Pharma) Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Halozyme (Antares Pharma) Needle-free Drug Injectors Product Portfolio
6.1.5 Halozyme (Antares Pharma) Recent Developments/Updates
6.2 Inovio Pharmaceuticals
6.2.1 Inovio Pharmaceuticals Company Information
6.2.2 Inovio Pharmaceuticals Description and Business Overview
6.2.3 Inovio Pharmaceuticals Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Inovio Pharmaceuticals Needle-free Drug Injectors Product Portfolio
6.2.5 Inovio Pharmaceuticals Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Company Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo International Needle-free Drug Injectors Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Injex Pharma GmbH
6.4.1 Injex Pharma GmbH Company Information
6.4.2 Injex Pharma GmbH Description and Business Overview
6.4.3 Injex Pharma GmbH Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Injex Pharma GmbH Needle-free Drug Injectors Product Portfolio
6.4.5 Injex Pharma GmbH Recent Developments/Updates
6.5 National Medical Products (J-Tip)
6.5.1 National Medical Products (J-Tip) Company Information
6.5.2 National Medical Products (J-Tip) Description and Business Overview
6.5.3 National Medical Products (J-Tip) Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 National Medical Products (J-Tip) Needle-free Drug Injectors Product Portfolio
6.5.5 National Medical Products (J-Tip) Recent Developments/Updates
6.6 Recipharm
6.6.1 Recipharm Company Information
6.6.2 Recipharm Description and Business Overview
6.6.3 Recipharm Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Recipharm Needle-free Drug Injectors Product Portfolio
6.6.5 Recipharm Recent Developments/Updates
6.7 InsuJet
6.7.1 InsuJet Company Information
6.7.2 InsuJet Description and Business Overview
6.7.3 InsuJet Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.7.4 InsuJet Needle-free Drug Injectors Product Portfolio
6.7.5 InsuJet Recent Developments/Updates
6.8 Miracle Medical
6.8.1 Miracle Medical Company Information
6.8.2 Miracle Medical Description and Business Overview
6.8.3 Miracle Medical Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Miracle Medical Needle-free Drug Injectors Product Portfolio
6.8.5 Miracle Medical Recent Developments/Updates
6.9 Medical International Technology (MIT)
6.9.1 Medical International Technology (MIT) Company Information
6.9.2 Medical International Technology (MIT) Description and Business Overview
6.9.3 Medical International Technology (MIT) Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medical International Technology (MIT) Needle-free Drug Injectors Product Portfolio
6.9.5 Medical International Technology (MIT) Recent Developments/Updates
6.10 Akra Dermojet
6.10.1 Akra Dermojet Company Information
6.10.2 Akra Dermojet Description and Business Overview
6.10.3 Akra Dermojet Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akra Dermojet Needle-free Drug Injectors Product Portfolio
6.10.5 Akra Dermojet Recent Developments/Updates
6.11 PharmaJet
6.11.1 PharmaJet Company Information
6.11.2 PharmaJet Description and Business Overview
6.11.3 PharmaJet Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 PharmaJet Needle-free Drug Injectors Product Portfolio
6.11.5 PharmaJet Recent Developments/Updates
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Description and Business Overview
6.12.3 Portal Instruments Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Portal Instruments Needle-free Drug Injectors Product Portfolio
6.12.5 Portal Instruments Recent Developments/Updates
6.13 Crossject
6.13.1 Crossject Company Information
6.13.2 Crossject Description and Business Overview
6.13.3 Crossject Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Crossject Needle-free Drug Injectors Product Portfolio
6.13.5 Crossject Recent Developments/Updates
6.14 Mika Medical
6.14.1 Mika Medical Company Information
6.14.2 Mika Medical Description and Business Overview
6.14.3 Mika Medical Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Mika Medical Needle-free Drug Injectors Product Portfolio
6.14.5 Mika Medical Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Description and Business Overview
6.15.3 Ferring Pharmaceuticals Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ferring Pharmaceuticals Needle-free Drug Injectors Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
6.16 IntegriMedical
6.16.1 IntegriMedical Company Information
6.16.2 IntegriMedical Description and Business Overview
6.16.3 IntegriMedical Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.16.4 IntegriMedical Needle-free Drug Injectors Product Portfolio
6.16.5 IntegriMedical Recent Developments/Updates
6.17 Helcomin
6.17.1 Helcomin Company Information
6.17.2 Helcomin Description and Business Overview
6.17.3 Helcomin Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Helcomin Needle-free Drug Injectors Product Portfolio
6.17.5 Helcomin Recent Developments/Updates
6.18 Nugen Medical
6.18.1 Nugen Medical Company Information
6.18.2 Nugen Medical Description and Business Overview
6.18.3 Nugen Medical Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Nugen Medical Needle-free Drug Injectors Product Portfolio
6.18.5 Nugen Medical Recent Developments/Updates
6.19 Lepu Medical
6.19.1 Lepu Medical Company Information
6.19.2 Lepu Medical Description and Business Overview
6.19.3 Lepu Medical Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Lepu Medical Needle-free Drug Injectors Product Portfolio
6.19.5 Lepu Medical Recent Developments/Updates
6.20 Beijing Quinovare
6.20.1 Beijing Quinovare Company Information
6.20.2 Beijing Quinovare Description and Business Overview
6.20.3 Beijing Quinovare Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Beijing Quinovare Needle-free Drug Injectors Product Portfolio
6.20.5 Beijing Quinovare Recent Developments/Updates
6.21 Qingdao Zhonghui Health Industrial Group
6.21.1 Qingdao Zhonghui Health Industrial Group Company Information
6.21.2 Qingdao Zhonghui Health Industrial Group Description and Business Overview
6.21.3 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product Portfolio
6.21.5 Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-free Drug Injectors Industry Chain Analysis
7.2 Needle-free Drug Injectors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-free Drug Injectors Production Mode & Process
7.4 Needle-free Drug Injectors Sales and Marketing
7.4.1 Needle-free Drug Injectors Sales Channels
7.4.2 Needle-free Drug Injectors Distributors
7.5 Needle-free Drug Injectors Customers
8 Needle-free Drug Injectors Market Dynamics
8.1 Needle-free Drug Injectors Industry Trends
8.2 Needle-free Drug Injectors Market Drivers
8.3 Needle-free Drug Injectors Market Challenges
8.4 Needle-free Drug Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Needle-free Drug Injectors Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Needle-free Drug Injectors Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Needle-free Drug Injectors Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Needle-free Drug Injectors Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Needle-free Drug Injectors Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Needle-free Drug Injectors Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Needle-free Drug Injectors Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Needle-free Drug Injectors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Needle-free Drug Injectors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Needle-free Drug Injectors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Needle-free Drug Injectors, Product Type & Application
 Table 12. Global Key Manufacturers of Needle-free Drug Injectors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Needle-free Drug Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-free Drug Injectors as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Needle-free Drug Injectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Needle-free Drug Injectors Sales by Region (2019-2024) & (K Units)
 Table 18. Global Needle-free Drug Injectors Sales Market Share by Region (2019-2024)
 Table 19. Global Needle-free Drug Injectors Sales by Region (2025-2030) & (K Units)
 Table 20. Global Needle-free Drug Injectors Sales Market Share by Region (2025-2030)
 Table 21. Global Needle-free Drug Injectors Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Needle-free Drug Injectors Revenue Market Share by Region (2019-2024)
 Table 23. Global Needle-free Drug Injectors Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Needle-free Drug Injectors Revenue Market Share by Region (2025-2030)
 Table 25. North America Needle-free Drug Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Needle-free Drug Injectors Sales by Country (2019-2024) & (K Units)
 Table 27. North America Needle-free Drug Injectors Sales by Country (2025-2030) & (K Units)
 Table 28. North America Needle-free Drug Injectors Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Needle-free Drug Injectors Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Needle-free Drug Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Needle-free Drug Injectors Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Needle-free Drug Injectors Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Needle-free Drug Injectors Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Needle-free Drug Injectors Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Needle-free Drug Injectors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Needle-free Drug Injectors Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Needle-free Drug Injectors Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Needle-free Drug Injectors Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Needle-free Drug Injectors Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Needle-free Drug Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Needle-free Drug Injectors Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Needle-free Drug Injectors Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Needle-free Drug Injectors Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Needle-free Drug Injectors Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Needle-free Drug Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Needle-free Drug Injectors Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Needle-free Drug Injectors Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Needle-free Drug Injectors Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Needle-free Drug Injectors Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Needle-free Drug Injectors Sales (K Units) by Type (2019-2024)
 Table 51. Global Needle-free Drug Injectors Sales (K Units) by Type (2025-2030)
 Table 52. Global Needle-free Drug Injectors Sales Market Share by Type (2019-2024)
 Table 53. Global Needle-free Drug Injectors Sales Market Share by Type (2025-2030)
 Table 54. Global Needle-free Drug Injectors Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Needle-free Drug Injectors Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Needle-free Drug Injectors Revenue Market Share by Type (2019-2024)
 Table 57. Global Needle-free Drug Injectors Revenue Market Share by Type (2025-2030)
 Table 58. Global Needle-free Drug Injectors Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Needle-free Drug Injectors Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Needle-free Drug Injectors Sales (K Units) by Application (2019-2024)
 Table 61. Global Needle-free Drug Injectors Sales (K Units) by Application (2025-2030)
 Table 62. Global Needle-free Drug Injectors Sales Market Share by Application (2019-2024)
 Table 63. Global Needle-free Drug Injectors Sales Market Share by Application (2025-2030)
 Table 64. Global Needle-free Drug Injectors Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Needle-free Drug Injectors Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Needle-free Drug Injectors Revenue Market Share by Application (2019-2024)
 Table 67. Global Needle-free Drug Injectors Revenue Market Share by Application (2025-2030)
 Table 68. Global Needle-free Drug Injectors Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Needle-free Drug Injectors Price (US$/Unit) by Application (2025-2030)
 Table 70. Halozyme (Antares Pharma) Company Information
 Table 71. Halozyme (Antares Pharma) Description and Business Overview
 Table 72. Halozyme (Antares Pharma) Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Halozyme (Antares Pharma) Needle-free Drug Injectors Product
 Table 74. Halozyme (Antares Pharma) Recent Developments/Updates
 Table 75. Inovio Pharmaceuticals Company Information
 Table 76. Inovio Pharmaceuticals Description and Business Overview
 Table 77. Inovio Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Inovio Pharmaceuticals Needle-free Drug Injectors Product
 Table 79. Inovio Pharmaceuticals Recent Developments/Updates
 Table 80. Endo International Company Information
 Table 81. Endo International Description and Business Overview
 Table 82. Endo International Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Endo International Needle-free Drug Injectors Product
 Table 84. Endo International Recent Developments/Updates
 Table 85. Injex Pharma GmbH Company Information
 Table 86. Injex Pharma GmbH Description and Business Overview
 Table 87. Injex Pharma GmbH Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Injex Pharma GmbH Needle-free Drug Injectors Product
 Table 89. Injex Pharma GmbH Recent Developments/Updates
 Table 90. National Medical Products (J-Tip) Company Information
 Table 91. National Medical Products (J-Tip) Description and Business Overview
 Table 92. National Medical Products (J-Tip) Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. National Medical Products (J-Tip) Needle-free Drug Injectors Product
 Table 94. National Medical Products (J-Tip) Recent Developments/Updates
 Table 95. Recipharm Company Information
 Table 96. Recipharm Description and Business Overview
 Table 97. Recipharm Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Recipharm Needle-free Drug Injectors Product
 Table 99. Recipharm Recent Developments/Updates
 Table 100. InsuJet Company Information
 Table 101. InsuJet Description and Business Overview
 Table 102. InsuJet Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. InsuJet Needle-free Drug Injectors Product
 Table 104. InsuJet Recent Developments/Updates
 Table 105. Miracle Medical Company Information
 Table 106. Miracle Medical Description and Business Overview
 Table 107. Miracle Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Miracle Medical Needle-free Drug Injectors Product
 Table 109. Miracle Medical Recent Developments/Updates
 Table 110. Medical International Technology (MIT) Company Information
 Table 111. Medical International Technology (MIT) Description and Business Overview
 Table 112. Medical International Technology (MIT) Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Medical International Technology (MIT) Needle-free Drug Injectors Product
 Table 114. Medical International Technology (MIT) Recent Developments/Updates
 Table 115. Akra Dermojet Company Information
 Table 116. Akra Dermojet Description and Business Overview
 Table 117. Akra Dermojet Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Akra Dermojet Needle-free Drug Injectors Product
 Table 119. Akra Dermojet Recent Developments/Updates
 Table 120. PharmaJet Company Information
 Table 121. PharmaJet Description and Business Overview
 Table 122. PharmaJet Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. PharmaJet Needle-free Drug Injectors Product
 Table 124. PharmaJet Recent Developments/Updates
 Table 125. Portal Instruments Company Information
 Table 126. Portal Instruments Description and Business Overview
 Table 127. Portal Instruments Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Portal Instruments Needle-free Drug Injectors Product
 Table 129. Portal Instruments Recent Developments/Updates
 Table 130. Crossject Company Information
 Table 131. Crossject Description and Business Overview
 Table 132. Crossject Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Crossject Needle-free Drug Injectors Product
 Table 134. Crossject Recent Developments/Updates
 Table 135. Mika Medical Company Information
 Table 136. Mika Medical Description and Business Overview
 Table 137. Mika Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Mika Medical Needle-free Drug Injectors Product
 Table 139. Mika Medical Recent Developments/Updates
 Table 140. Ferring Pharmaceuticals Company Information
 Table 141. Ferring Pharmaceuticals Description and Business Overview
 Table 142. Ferring Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Ferring Pharmaceuticals Needle-free Drug Injectors Product
 Table 144. Ferring Pharmaceuticals Recent Developments/Updates
 Table 145. IntegriMedical Company Information
 Table 146. IntegriMedical Description and Business Overview
 Table 147. IntegriMedical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. IntegriMedical Needle-free Drug Injectors Product
 Table 149. IntegriMedical Recent Developments/Updates
 Table 150. Helcomin Company Information
 Table 151. Helcomin Description and Business Overview
 Table 152. Helcomin Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Helcomin Needle-free Drug Injectors Product
 Table 154. Helcomin Recent Developments/Updates
 Table 155. Nugen Medical Company Information
 Table 156. Nugen Medical Description and Business Overview
 Table 157. Nugen Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Nugen Medical Needle-free Drug Injectors Product
 Table 159. Nugen Medical Recent Developments/Updates
 Table 160. Lepu Medical Company Information
 Table 161. Lepu Medical Description and Business Overview
 Table 162. Lepu Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Lepu Medical Needle-free Drug Injectors Product
 Table 164. Lepu Medical Recent Developments/Updates
 Table 165. Beijing Quinovare Company Information
 Table 166. Beijing Quinovare Description and Business Overview
 Table 167. Beijing Quinovare Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Beijing Quinovare Needle-free Drug Injectors Product
 Table 169. Beijing Quinovare Recent Developments/Updates
 Table 170. Qingdao Zhonghui Health Industrial Group Company Information
 Table 171. Qingdao Zhonghui Health Industrial Group Description and Business Overview
 Table 172. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product
 Table 174. Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Needle-free Drug Injectors Distributors List
 Table 178. Needle-free Drug Injectors Customers List
 Table 179. Needle-free Drug Injectors Market Trends
 Table 180. Needle-free Drug Injectors Market Drivers
 Table 181. Needle-free Drug Injectors Market Challenges
 Table 182. Needle-free Drug Injectors Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Needle-free Drug Injectors
 Figure 2. Global Needle-free Drug Injectors Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Needle-free Drug Injectors Market Share by Type: 2023 & 2030
 Figure 4. Powder Injections Product Picture
 Figure 5. Liquid Injections Product Picture
 Figure 6. Depot or Projectile Injection Product Picture
 Figure 7. Global Needle-free Drug Injectors Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Needle-free Drug Injectors Market Share by Application: 2023 & 2030
 Figure 9. Vaccine Delivery
 Figure 10. Insulin Delivery
 Figure 11. Others
 Figure 12. Global Needle-free Drug Injectors Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Needle-free Drug Injectors Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Needle-free Drug Injectors Sales (2019-2030) & (K Units)
 Figure 15. Global Needle-free Drug Injectors Average Price (US$/Unit) & (2019-2030)
 Figure 16. Needle-free Drug Injectors Report Years Considered
 Figure 17. Needle-free Drug Injectors Sales Share by Manufacturers in 2023
 Figure 18. Global Needle-free Drug Injectors Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Needle-free Drug Injectors Players: Market Share by Revenue in Needle-free Drug Injectors in 2023
 Figure 20. Needle-free Drug Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Needle-free Drug Injectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Needle-free Drug Injectors Sales Market Share by Country (2019-2030)
 Figure 23. North America Needle-free Drug Injectors Revenue Market Share by Country (2019-2030)
 Figure 24. United States Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Needle-free Drug Injectors Sales Market Share by Country (2019-2030)
 Figure 27. Europe Needle-free Drug Injectors Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Needle-free Drug Injectors Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Needle-free Drug Injectors Revenue Market Share by Region (2019-2030)
 Figure 35. China Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Needle-free Drug Injectors Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Needle-free Drug Injectors Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Needle-free Drug Injectors Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Needle-free Drug Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Needle-free Drug Injectors by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Needle-free Drug Injectors by Type (2019-2030)
 Figure 54. Global Needle-free Drug Injectors Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Needle-free Drug Injectors by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Needle-free Drug Injectors by Application (2019-2030)
 Figure 57. Global Needle-free Drug Injectors Price (US$/Unit) by Application (2019-2030)
 Figure 58. Needle-free Drug Injectors Value Chain
 Figure 59. Needle-free Drug Injectors Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String